Piper Jaffray & Co. upgrades BioScrip, Inc. (Nasdaq: BIOS) to Overweight. Price target $7.50.

Piper analyst says, "We are upgrading ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE